Jacoline Bouvy

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. doi request reprint Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysis
    J C Bouvy
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands Department of Health Policy and Management iBMG, Institute for Medical Technology Assessment, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    Acta Neurol Scand 127:351-9. 2013
  2. doi request reprint The cost-effectiveness of periodic safety update reports for biologicals in europe
    J C Bouvy
    Utrecht Institute for Pharmaceutical Sciences UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
    Clin Pharmacol Ther 93:433-42. 2013
  3. doi request reprint The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies
    J C Bouvy
    Institute for Medical Technology Assessment, Faculty of Health, Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Clin Pharmacol Ther 91:281-8. 2012
  4. doi request reprint Willingness to pay for adverse drug event regulatory actions
    Jacoline Bouvy
    Institute for Medical Technology Assessment, Department of Health Policy and Management iBMG, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 29:963-75. 2011

Detail Information

Publications4

  1. doi request reprint Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysis
    J C Bouvy
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands Department of Health Policy and Management iBMG, Institute for Medical Technology Assessment, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    Acta Neurol Scand 127:351-9. 2013
    ..To assess the cost-effectiveness of endovascular treatment against intravenous thrombolysis (IVT) when varying assumptions concerning its effectiveness...
  2. doi request reprint The cost-effectiveness of periodic safety update reports for biologicals in europe
    J C Bouvy
    Utrecht Institute for Pharmaceutical Sciences UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
    Clin Pharmacol Ther 93:433-42. 2013
    ..It is possible to assess the cost-effectiveness of regulatory requirements using the same methods as those used in assessing the cost-effectiveness of medical interventions...
  3. doi request reprint The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies
    J C Bouvy
    Institute for Medical Technology Assessment, Faculty of Health, Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Clin Pharmacol Ther 91:281-8. 2012
    ..Our study shows that cost-effectiveness analysis of drug regulatory measures is feasible and should be considered before developing such measures...
  4. doi request reprint Willingness to pay for adverse drug event regulatory actions
    Jacoline Bouvy
    Institute for Medical Technology Assessment, Department of Health Policy and Management iBMG, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 29:963-75. 2011
    ..Regulatory requirements for the pharmaceutical industry have become increasingly demanding with respect to the safety and effectiveness of drugs...